Natera (NASDAQ:NTRA) Price Target Raised to $185.00
Natera (NASDAQ:NTRA – Free Report) had its price target increased by Morgan Stanley from $176.00 to $185.00 in a report released on Wednesday,Benzinga reports. They currently have an overweight rating on the medical research company’s stock. Several other analysts also recently issued reports on NTRA. Piper Sandler raised their price objective on shares of Natera […]
Natera (NASDAQ:NTRA – Free Report) had its price target increased by Morgan Stanley from $176.00 to $185.00 in a report released on Wednesday,Benzinga reports. They currently have an overweight rating on the medical research company’s stock. Several other analysts also recently issued reports on NTRA. Piper Sandler raised their price objective on shares of Natera […]
